Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a leading science-driven biotechnology company that invents life-transforming medicines for serious medical conditions. The company utilizes its proprietary VelociSuite technologies to accelerate antibody discovery and commercializes breakthrough treatments including Eylea for retinal diseases and Dupixent for severe inflammatory conditions. By pairing human genetics research with high-throughput antibody engineering, Regeneron Pharmaceuticals delivers therapies across ophthalmology, immunology, and oncology.